DeepSeek V3.2 vs Llama 4 Maverick
Compare DeepSeek V3.2 by DeepSeek against Llama 4 Maverick by Meta AI, context windows of 131K vs 1.0M, tested across 28 shared challenges. Updated February 2026.
Compare DeepSeek V3.2 by DeepSeek against Llama 4 Maverick by Meta AI, context windows of 131K vs 1.0M, tested across 28 shared challenges. Updated February 2026.
23 challenges
Tests an AI's ability to generate vector graphics
Tests an AI's ability to create detailed SVG illustrations of gaming hardware
Tests an AI's ability to generate a complete, working landing page
Recreate an interactive, classic Mario level in a single HTML file.
Tests an AI's ability to replicate an existing UI with Tailwind CSS
Tests an AI's ability to create interactive web elements
Tests an AI's ability to create a detailed world map in SVG format
Generate a unique and simple recipe with common ingredients.
Create a starter plan for improving long-term health.
Recreate a classic, retro, macOS Desktop UI — make it interactive and nostalgic, make it as interactive as you can, you can be creative.. Feel free to showcase your skills. The entire application must be a single-page self-contained HTML file.
Develop a cutting-edge 3-month longevity plan for a biohacker.
Morning (5:30-7:00 AM):
Nutrition (Time-Restricted Eating 8-hour window):
Supplement Stack (Mon-Fri):
Exercise Protocol:
Advanced Fasting Regimen:
Supplement Additions:
Cognitive Enhancement:
Advanced Tracking:
Recovery Protocols:
Genetic-Based Adjustments:
Circadian Optimization:
Advanced Exercise Protocols:
Final Testing & Protocol Lock:
This protocol represents the current cutting edge of longevity biohacking, integrating nutritional biochemistry, advanced technology, and personalized medicine. Regular adaptation based on biomarker response is crucial for optimal results.
3-Month Longevity Plan for Biohackers
Disclaimer: Before starting any new supplement or exercise regimen, consult with a healthcare professional to ensure safety and suitability.
Month 1: Optimization and Baseline Establishment
Month 2: Intensification and Refining
Month 3: Peak Performance and Long-Term Optimization
Additional Recommendations:
Action Plan:
By following this comprehensive 3-month plan, biohackers can optimize their longevity, physical and cognitive performance, and develop a robust foundation for long-term health and well-being.
Write a pro-level buy-side investment memo with valuation and diligence questions.
Investment Committee Memo: LedgerLift (LLLT)
1. Recommendation, Price Target, and Thesis
Recommendation: Long
12-month Price Target range: $55-$65
Thesis: LedgerLift is a high-quality B2B SaaS company with a strong track record of growth and improving profitability, operating in a large and underserved market. The current share price underestimates the company's potential for continued growth and margin expansion.
2. Business and Competitive Advantage
LedgerLift provides B2B spend management and AP automation SaaS solutions to mid-market enterprises. The company's platform helps customers streamline their financial operations, reduce costs, and improve visibility into their spend. LedgerLift's competitive advantage lies in its comprehensive solution, ease of implementation, and strong customer support, which have enabled the company to achieve high customer retention and net revenue retention (NRR) rates. The mid-market enterprise segment is large and underserved, providing LedgerLift with a significant opportunity for growth.
3. KPI Quality Check
Potential concerns:
4. Base/Bull/Bear Model
| 2026 | 2027 | 2028 | 2029 | 2030 | |
|---|---|---|---|---|---|
| Base Case | |||||
| Revenue | $992m | $1,171m | $1,347m | $1,522m | $1,704m |
| EBIT | $198m | $257m | $323m | $381m | $443m |
| Unlevered FCF | $173m | $224m | $283m | $336m | $392m |
| Bull Case | |||||
| Revenue | $1,030m | $1,246m | $1,471m | $1,692m | $1,912m |
| EBIT | $216m | $299m | $382m | $474m | $554m |
| Unlevered FCF | $190m | $264m | $339m | $424m | $498m |
| Bear Case | |||||
| Revenue | $951m | $1,075m | $1,193m | $1,312m | $1,430m |
| EBIT | $162m | $194m | $227m | $262m | $300m |
| Unlevered FCF | $140m | $168m | $198m | $230m | $265m |
DCF valuation:
5. Comps Cross-Check
Median multiples: EV/NTM Revenue = 9.0x, EV/NTM EBIT = 35x
Implied EV: $6.1B - $7.4B (using NTM Revenue and EBIT estimates)
Implied Value per Share: $32.11 - $38.95
6. Catalysts, Risks, and "What Would Change My Mind"
Catalysts:
Risks:
"What Would Change My Mind":
7. Diligence Questions for Management